Stay updated with breaking news from Nasdaq Adap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report)’s share price traded down 5.3% during mid-day trading on Wednesday . The company traded as low as $1.08 and last traded at $1.08. 126,750 shares traded hands during trading, a decline of 93% from the average session volume of 1,761,175 shares. The stock had previously closed at […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $1.01, but opened at $1.04. Adaptimmune Therapeutics shares last traded at $1.08, with a volume of 119,471 shares trading hands. Wall Street Analysts Forecast Growth Separately, StockNews.com assumed coverage on shares of […]
Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) and NanoString Technologies (NASDAQ:NSTG – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk. Valuation and Earnings This table compares Adaptimmune […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $1.38, but opened at $1.45. Adaptimmune Therapeutics shares last traded at $1.44, with a volume of 159,111 shares trading hands. Analyst Ratings Changes Separately, StockNews.com initiated coverage on shares of Adaptimmune […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) was the recipient of a large drop in short interest in January. As of January 31st, there was short interest totalling 4,710,000 shares, a drop of 18.4% from the January 15th total of 5,770,000 shares. Based on an average trading volume of 1,230,000 shares, the days-to-cover ratio […]